| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/11/2010 | CA2739199A1 Dihydrotetrabenazine for treatment of asthma |
| 03/11/2010 | CA2735770A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
| 03/11/2010 | CA2735722A1 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
| 03/11/2010 | CA2735208A1 Novel benzamides, production thereof, and use thereof as medicaments |
| 03/10/2010 | EP2161329A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
| 03/10/2010 | EP2161252A1 N-Alkylcarbonyl-amino acid ester and N-Alkylcarbonyl-amino lactone compounds and their use |
| 03/10/2010 | EP2161032A2 Methods of healing wounds by administering human IL-18 |
| 03/10/2010 | EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof |
| 03/10/2010 | EP1682541B1 Method for producing tiotropium salts |
| 03/10/2010 | CN101664388A transnasal transport/immunisation with highly adaptable carriers |
| 03/09/2010 | US7674830 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors |
| 03/09/2010 | US7674777 Immunostimulatory nucleic acid molecules |
| 03/09/2010 | US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution |
| 03/09/2010 | US7674455 treating a mammal having amyotrophic lateral sclerosis by transducing a motor neuron of the mammal with an insulin-like growth factor I (IGF-1) gene or a glial cell line-derived neurotrophic factor (GDNF) gene; neurodegenerative disorders |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/09/2010 | CA2156007C Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 03/04/2010 | WO2010024956A2 Antihistamine and antihistamine-like nasal application, products, and method |
| 03/04/2010 | WO2010024298A1 Potassium channel regulator |
| 03/04/2010 | WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity |
| 03/04/2010 | WO2010009068A3 Cyclohexenyl modulators of chemokine receptor activity |
| 03/04/2010 | WO2010005520A3 Deuterated ibudilast |
| 03/04/2010 | WO2009152144A3 All day rhinitic condition treatment regimen |
| 03/04/2010 | WO2009143292A9 Method of treating pneumoconiosis with oligodeoxynucleotides |
| 03/04/2010 | WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 03/04/2010 | US20100057047 Delivery device and method |
| 03/04/2010 | US20100056637 Treatment methods using triaryl methane compounds |
| 03/04/2010 | US20100056571 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors |
| 03/04/2010 | US20100056565 Heterocyclic Derivatives as M3 Muscarinic Receptors |
| 03/04/2010 | US20100056559 Propellant-free aerosol formulation for inhalation |
| 03/04/2010 | US20100056558 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors |
| 03/04/2010 | US20100056544 Salts with CRTH2 Antagonist Activity |
| 03/04/2010 | US20100056528 Sulfonamide derivatives with therapeutic indications |
| 03/04/2010 | US20100056514 Thienopyrazoles |
| 03/04/2010 | US20100056496 Muscarinic receptor antagonists |
| 03/04/2010 | US20100056480 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis |
| 03/04/2010 | US20100056432 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2010 | US20100056429 Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 03/04/2010 | US20100055216 Pharmaceutical composition for inhibiting the syndrome of snoring and preparation thereof |
| 03/04/2010 | US20100055193 Stable powder formulation containing an anticholinergic agent |
| 03/04/2010 | US20100055164 Synthetic lung surfactant and use thereof |
| 03/04/2010 | US20100055093 Pan-cell surface receptor-specific therapeutics |
| 03/04/2010 | CA2726234A1 Antihistamine and antihistamine-like nasal application, products, and method |
| 03/03/2010 | EP2158911A1 Stable pharmaceutical formulations of montelukast sodium |
| 03/03/2010 | EP2018375B1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 03/03/2010 | EP1743648B1 Method for treating inflammation |
| 03/03/2010 | EP1505973B1 Combinations for treating multiple myeloma |
| 03/03/2010 | EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 03/03/2010 | EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 03/03/2010 | CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 03/03/2010 | CN100592919C Spray for treating chronic pharyngitis |
| 03/02/2010 | US7671252 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 03/02/2010 | US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV) |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671090 Inhibitors of α4 mediated cell adhesion |
| 03/02/2010 | US7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2010 | US7671071 Crystal structure; antihistamines; histamine H1-antagonists; side effect reduction; storage stability |
| 03/02/2010 | US7671053 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide for treatment of asthma and COPD; purinergic receptors (P2X7) |
| 03/02/2010 | US7671037 Hypoxia induced mitogenic factor |
| 03/02/2010 | US7670625 Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent |
| 03/02/2010 | CA2394615C Substituted 1,3,4-oxadiazoles and a method of reducing tnf-.alpha. levels |
| 02/25/2010 | WO2010022358A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoio[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | WO2010022043A2 Targeting of histone deacetylase 2 and protein kinase ck2 for treatment of inflammatory diseases |
| 02/25/2010 | WO2010021385A1 Therapeutic agent for anca-related vasculitis |
| 02/25/2010 | WO2010020366A1 Azabicyclic substituted 5-aminopyrazoles and the use thereof |
| 02/25/2010 | WO2008144347A8 Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections |
| 02/25/2010 | US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 02/25/2010 | US20100048684 EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRES METALLOPROTEINASE CLEAVAGE OF proHB-EGF |
| 02/25/2010 | US20100048651 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 02/25/2010 | US20100048648 Thiophene derivatives as S1P1/EDGE1 receptor agonists |
| 02/25/2010 | US20100048621 Medicament for treating chronic obstructive pulmonary disease |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048568 Pyrimidine hydrazide compounds as pgds inhibitors |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048560 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 02/25/2010 | US20100048558 Thienopyridines |
| 02/25/2010 | US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases |
| 02/25/2010 | US20100048547 Pi 3-kinase inhibitors and methods of their use |
| 02/25/2010 | US20100048513 Novel inhibitors of chymase |
| 02/25/2010 | US20100048496 Core 2 GlcNAc-T inhibitors |
| 02/25/2010 | US20100048475 Method of Treating Dyspnea Associated with Acute Heart Failure |
| 02/25/2010 | US20100048457 Glycoprotein for treating chronic obstructive pulmonary diseases |
| 02/25/2010 | US20100047340 Hot-melt extrusion of modified release multi-particulates |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047215 Stem cell targeting methods |
| 02/25/2010 | CA2735130A1 Compounds and methods for treating respiratory diseases |
| 02/25/2010 | CA2735048A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | CA2734870A1 Therapeutic agent for anca-related vasculitis |
| 02/24/2010 | EP2157087A1 3-(4-{[4-(4-{[3-(3,3-dimethyl-1-piperidinyl)propyl]oxy}phenyl)-1-piperidinyl]carbonyl}-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 02/24/2010 | EP2157084A1 5-phenyl-3-pyridazinone derivative |
| 02/24/2010 | EP2156840A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 02/24/2010 | EP2155721A1 Organic compounds |
| 02/24/2010 | EP2155711A1 Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| 02/24/2010 | EP2155689A2 Ccr2 receptor antagonists and uses thereof |
| 02/24/2010 | EP2155205A1 Treatment of meconium aspiration syndrome with estrogens |
| 02/24/2010 | EP2155202A2 3,6-disubstituted-imidazo[1,2-b]pyridazines and 3,5-disubstituted pyrazolo[1,5-a]pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | CN201409485Y Breathing mask for treating rhinitis |
| 02/24/2010 | CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 02/24/2010 | CN101653604A Anti-ngf antibodies for the treatment of various disorders |
| 02/24/2010 | CN100591329C Montelukast granule formulation |